Johnson & Johnson (JNJ) Stock Price, Quote, News & History

JNJNYSE

Trade with Public

$238.46

-2.85-1.18%

At close: Apr 10, 5:00 PM EST

$238.94

0.470.20%

After Hours: Apr 10, 7:41 PM EST

Earnings: Q1 2026 earnings tomorrow on Tue Apr 14th before the market open

Conference Call: Conference call scheduled tomorrow at 8:30 AM

Click to view the webcast

OverviewNews Earnings Options Guidance Dividends Analyst Ratings Insider Trades Short Interest Government Trades Stock Report

Key Statistics

Open

$242.00

$238.46

Volume / Avg.

7.35M / 8.77M

Day Range

$237.91 - $242.26

52 Wk Range

141.50 - 251.71

Market Cap

$575.81B

P/E Ratio

21.88

Dividend Yield

2.15%

Exchange

NYSE

RSI

Short Interest

0.92%

Days to Cover

2.76

Recent Johnson & Johnson News

Johnson & Johnson Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call

JNJ (NYSE: JNJ) to release Q1 earnings before bell on April 14. Analysts expect $2.67/share & $23.6B revenue. FDA approves TECNIS PureSee lens.

Avi Kapoor

Microsoft Is Now The Biggest Deadweight On S&P 500 — And Exxon Is What Nvidia Used To Be

Microsoft is the single biggest drag on the S&P 500 this year and all of the Magnificent 7 stocks are deadweight on headline returns.

Erica Kollmann

Trump Administration Prepares 100% Tariffs On Drugmakers Without Pricing Deals: Report

According to a Bloomberg report, Trump may impose 100% tariffs on drugmakers without pricing deals, as part of a broader push to lower drug costs.

Tanya Rawat

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

24.53B

Investing Cash Flow (TTM)

-23.59B

Financing Cash Flow (TTM)

-5.54B

Free Cash Flow (TTM)

19.31B

Capital Expenditure (TTM)

-5.22B

Net Change in Cash (TTM)

-4.60B

Analyst Trends and Forecast

Jan

Feb

Mar

Apr

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

3.2

Hold

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$602.19B

PE Ratio (TTM)

21.88

PE Ratio (FWD)

20.92

PEG Ratio (TTM)

1.69

PS Ratio (TTM)

6.22

PB Ratio (TTM)

7.13

Earnings Yield % (TTM)

4.57%

Earnings Yield % (FWD)

4.78%

EV / EBITDA (TTM)

14.84

Price / EBITDA (TTM)

14.28

Price / Free Cash Flow (TTM)

30.35

Book Value / Share

$33.86

Company Debt

Total Debt

$47.93B

LT Debt

$39.44B

LT Debt Issuance (TTM)

$9.14B

LT Debt Repayment (TTM)

-$1.76B

Total Cash

$19.71B

Debt to Equity

0.59

Issuance of Debt (TTM)

$7.38B

Repayment of Debt (TTM)

-$14.09B

Key Statistics

Open

$242.00

$238.46

Volume / Avg.

7.35M / 8.77M

Day Range

$237.91 - $242.26

52 Wk Range

141.50 - 251.71

Market Cap

$575.81B

P/E Ratio

21.88

Dividend Yield

2.15%

Exchange

NYSE

RSI

Short Interest

0.92%

Days to Cover

2.76

About

Sector

Health Care

Industry

Pharmaceuticals

Johnson & Johnson is the world's largest and most diverse healthcare firm. It has two divisions: innovative medicine and medtech. These now represent all of the company's sales following the divestment of the consumer business, Kenvue, in 2023. After...

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS better than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS better than industry